Skip to main content
ANIP
NASDAQ Life Sciences

ANI Pharma Offers to Buy Sweden's Egetis Therapeutics to Bolster Rare Disease Franchise

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$72
Mkt Cap
$1.646B
52W Low
$69.58
52W High
$95.57
52W Position info
3.5% above low
Off High info
25% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

ANIP is trading near its 52-week low of $69.58 (3.5% above the low).

Summary

ANI Pharmaceuticals said it has made an offer to acquire Egetis Therapeutics at SEK 11.25 per Egetis share, a move aimed at widening the scope and scale of its rare disease business. The deal would build on a portfolio already anchored by Cortrophin Gel and the recently approved Everolimus oral suspension, and it lands with ANIP shares trading near their 52-week low of $69.58 against a $95.57 high. The key open questions are whether the offer is cash or stock and how ANI would fund it — the company has a $100M buyback authorized since May, so a large cash outlay would compete with that program. Egetis is a Swedish-listed company, so the offer likely requires a public tender and regulatory clearances; watch for Egetis board response and any disclosed valuation.

At the time of this announcement, ANIP was trading at $72.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $69.58 to $95.57. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

ANIP - Latest Insights

ANIP
Nov 05, 2026, 5:13 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $69.00
Real-time Price: $70.08 info
Change: +$1.08 (+2%) info
Market Cap: $1.593B info
ANIP
Nov 05, 2026, 6:58 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $75.00
Real-time Price: $70.08 info
Change: -$4.92 (-7%) info
Market Cap: $1.593B info
ANIP
Nov 05, 2026, 6:56 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $71.72
Real-time Price: $70.08 info
Change: -$1.64 (-2%) info
Market Cap: $1.593B info
ANIP
Nov 05, 2026, 6:51 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $72.00
Real-time Price: $70.08 info
Change: -$1.92 (-3%) info
Market Cap: $1.593B info
ANIP
Oct 12, 2026, 6:55 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $73.86
Real-time Price: $70.08 info
Change: -$3.78 (-5%) info
Market Cap: $1.593B info